Market Tracker

08/01 3:32am ET

Repligen Corp (NASDAQ:RGEN)

20.97
Data as of Jul 31
 -1.44 / -6.43%
Today’s Change
9.41
Today|||52-Week Range
24.68
+53.74%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close22.41
Today’s open22.19
Day’s range20.94 - 22.19
Volume432,606
Average volume (3 months)502,523
Market cap$718.0M
Dividend yield--
Data as of 4:00pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio38.1
Price/Sales6.34
Price/Book6.89

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...0.000.00%
SAGESAGE Therapeutics In...+0.62+2.25%
ACHNAchillion Pharmaceut...-0.43-5.91%
ANACAnacor Pharmaceutica...-0.15-0.89%
Data as of 4:00pm ET, 07/31/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)$0.06
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Senior Vice President-
Global Operations
Daniel P. Witt
Corporate headquarters
Waltham, Massachusetts

Forecasts